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Introduction
Ventilatory strategies that reduce lung stretch by reduc-
ing tidal and minute ventilation, which results in a 
‘permissive’ hypercapnic acidosis, improve outcome in 
patients with acute lung injury/acute respiratory distress 
syndrome (ALI/ARDS) [1,2]. Reassuringly, evidence from 
clinical studies attests to the safety and lack of detri-
mental eﬀ  ects of hypercapnic acidosis [2]. Of parti  cu  lar 
importance, a secondary analysis of data from the 
ARDSnet tidal volume study [1] demonstrated that the 
presence of hypercapnic acidosis at the time of randomi-
zation was associated with improved patient survival in 
patients who received high tidal volume ventilation [3]. 
Th  ese ﬁ   ndings have resulted in a shift in paradigms 
regarding hypercapnia – from avoidance to tolerance – 
with hypercapnia increasingly permitted in order to 
realize the beneﬁ  ts of low lung stretch. Conse  quently, low 
tidal and minute volume ventilation and the accom-
panying `permissive’ hypercapnia are now the standard 
of care for patients with ALI/ARDS, and are increasingly 
used in the ventilatory management of a diverse range of 
diseases leading to acute severe respira  tory failure, inclu-
d  ing asthma and chronic obstructive pulmonary disease.
Th  e inﬂ  ammatory response plays a central role in the 
pathogenesis of injury and in the repair process in ALI/
ARDS [4]. Inﬂ  ammation is a highly conserved process in 
evolution, which is essential for survival. It functions to 
resolve the injurious process, facilitate repair, and return 
the host to a state of homeostasis. Th   e ideal inﬂ  ammatory 
process is rapid, causes focused destruction of pathogens, 
yet is speciﬁ  c and ultimately self-limiting [5]. In contrast, 
when the inﬂ  ammatory response is dysregulated or persis-
tent, this can lead to excessive host damage, and 
contribute to the pathogenesis of lung and systemic organ 
injury, leading to multiple organ failure and death. Th  e 
potential for hypercapnia and/or its associated acidosis to 
potently inhibit the immune response is increasingly 
recognized [6,7]. Where the host immune response is a 
major contri  bu  tor to injury, such as in non-septic ALI/
ARDS, these eﬀ   ects would be expected to result in 
potential beneﬁ  t. Th  is has been demonstrated clearly in 
relevant pre-clinical ALI/ARDS models, where hyper-
capnic acidosis has been demonstrated to attenuate ALI 
induced by free radicals [8], pulmonary [9] and systemic 
ischemia-reperfusion [10], pulmonary endo  toxin instilla-
tion [11], and excessive lung stretch [12]. Th  e protective 
eﬀ  ects of hypercapnic acidosis in these models appear 
due, at least in part, to its anti-inﬂ  ammatory eﬀ  ects.
Th  e eﬀ   ects of hypercapnia in sepsis-induced lung 
injury, where a robust immune response to microbial 
infec  tion is central to bacterial clearance and recovery, is 
less clear. Of concern, severe sepsis-induced organ 
failure, whether pulmonary or systemic in origin, is the 
leading cause of death in critically ill adults and children 
[13]. Sepsis-induced ARDS is associated with the highest 
mortality rates. Evidence suggests that approximately 
40% of patients with severe sepsis develop ARDS [13]. 
Furthermore, infection frequently complicates critical 
illness due to other causes, with an infection prevalence 
of over 44% reported in this population [14]. Th  ese  issues 
underline the importance of understanding the eﬀ  ects of 
hypercapnia on the immune response, and the implica-
tions of these eﬀ  ects in the setting of sepsis.
Hypercapnia and the innate immune response
Function of the innate immune response
Th   e immune system can be viewed as having two inter-
connected branches, namely the innate and adaptive 
immune responses [5]. Th   e innate immune system is an 
ancient, highly conserved response, being present in 
Can ‘permissive’ hypercapnia modulate the 
severity of sepsis-induced ALI/ARDS?
Gerard Curley, Mairead Hayes, and John G Laff  ey*
This article is one of eleven reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2011 (Springer Verlag) and 
co-published as a series in Critical Care. Other articles in the series can be found online at http://ccforum.com/series/annual. Further 
information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901
REVIEW
*Correspondence: john.laff  ey@nuigalway.ie
Department of Anestheisa, Clinical Sciences Institute, National University, Galway, 
Ireland
Curley et al. Critical Care 2011, 15:212 
http://ccforum.com/content/15/2/212
© 2011 Springer-Verlag Berlin Heidelberg.
This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifi  cally the rights of 
translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi  lm or in any other way, and storage in data 
banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 
1965, in its current version, and permission for use must always be obtained from Springer-Verlag. Violations are liable for prosecution 
under the German Copyright Law.some form in all metazoan organisms. Th  is response is 
activated by components of the wall of invading micro-
organisms, such as lipopolysaccharide (LPS) or peptido-
glycan, following the binding of these pathogen-asso-
ciated molecular patterns to pattern recognition recep-
tors, such as the Toll-like receptors (TLRs) on tissue 
macrophages. Th   e innate immune response is also activa-
ted by endogenous `danger’ signals, such as mitochon-
drial components [15], providing an elegant explanation 
for why non-septic insults can also lead to organ injury 
and dysfunction. An inﬂ   ammatory cascade is then 
initiated, involving cytokine signaling activation of 
phago  cytes that kill bacteria, as is activation of the (later) 
adaptive immune response.
Activation of the innate immune response
Hypercapnic acidosis has been demonstrated to inhibit 
multiple components of the host innate immune res-
ponses. Activation of the innate immune response 
initiates a conserved signaling cascade that culminates in 
the activation of transcription factors, such as nuclear 
factor kappa-B (NF-κB) [5]. Th  ese transcription factors 
drive the expression of multiple genes that activate and 
regulate the pro-inﬂ   ammatory and repair processes. 
Increasing evidence suggests that hypercapnic acidosis 
directly inhibits the activation of NF-κB [16]. Intriguingly, 
this eﬀ  ect of hypercapnic acidosis may be a property of 
the CO2 rather than its associated acidosis [17–19]. If 
conﬁ   rmed, this ﬁ   nding suggests the presence of a 
molecular CO2 sensor in mammalian cells. Th  is  mecha-
nism of action of hypercapnic acidosis has been demon-
strated to underlie some of the anti-inﬂ  ammatory eﬀ  ects 
of hypercapnia [16], and to be a key mechanism by which 
hypercapnia – whether buﬀ   ered or not – reduces 
pulmonary epithelial wound healing [18].
Coordination of the innate immune response
Hypercapnic acidosis also interferes with coordination of 
the innate immune response by reducing cytokine signal-
ing between immune eﬀ  ector cells. Hypercapnic acidosis 
reduces neutrophil [20] and macrophage [21] production 
of pro-inﬂ  ammatory cytokines such as tumor necrosis 
factor (TNF)-α, interleukin (IL)-1β, IL-8 and IL-6. Hyper-
capnic acidosis reduced endotoxin stimulated macro-
phage release of TNFα and IL-1β in vitro [21]. Peritoneal 
macrophages incubated under hypercapnic conditions 
demonstrated a prolonged reduction in endotoxin-
stimulated TNF-α and IL-1β release [22]. In contrast, a 
recent study reported rapid onset and rapid reversibility 
of IL-6 inhibition by hypercapnia in mature macrophage 
stimulated with LPS [19]. Th  e mechanism underlying 
hypercapnic acidosis-mediated inhibition of cytokine 
and chemokine production appears to be mediated at 
least in part via inhibition of activation of NF-κB.
The cellular innate immune response
Neutrophils and macrophages are important eﬀ  ectors of 
the innate immune response in the setting of bacterial 
infection. Neutrophils rapidly migrate from the blood-
stream to areas of infection, and rapidly phagocytose 
invading microorganisms. Tissue macrophages and their 
blood borne monocyte counterparts are activated by 
bacterial products such as endotoxin, and coordinate the 
activation of the adaptive immune response in the setting 
of infection by presenting foreign antigen to lymphocytes 
and secreting chemokines. Both monocytes and 
macrophages phagocytose and kill pathogens by similar 
mechanisms but at a slower rate than neutrophils.
Hypercapnic acidosis may impact on the cellular 
immune response via both direct and indirect mecha-
nisms. Hypercapnic acidosis inhibits neutrophil expres-
sion of the chemokines, selectins and intercellular 
adhesion molecules [16,20], which facilitate neutrophil 
binding to the endothelium and migration out of the 
vascular system. Th  e potential for hypercapnic acidosis 
to inhibit neutrophil chemotaxis and migration to the 
site of injury has been conﬁ  rmed in vivo, where hyper-
capnic acidosis inhibits pulmonary neutrophil inﬁ  ltration 
in response to endotoxin instillation [11]. Hypercapnic 
acidosis directly impairs neutrophil phagocytosis in vitro 
[23]. Th   is inhibitory eﬀ  ect appears to be a function of the 
acidosis  per se, with buﬀ   ering restoring neutrophil 
phagocytosis [24]. Hypercapnic acidosis also inhibits 
phagocytosis of opsonized polystyrene beads by human 
alveolar macrophages, although the levels of CO2 utilized 
to demonstrate this eﬀ  ect were well beyond the range 
encountered clinically [19].
Neutrophils and macrophages kill ingested bacteria by 
producing free radicals such as superoxide, hydrogen 
peroxide, and hypochlorous acid, and releasing these into 
the phagosome. Th  is is a pH-dependent process, with 
free radical production decreased at low pH [25]. Hyper-
capnic acidosis inhibits the generation of oxidants such 
as superoxide by unstimulated neutrophils and by 
neutrophils stimulated with opsonized Escherichia coli or 
with phorbol esters [20]. In contrast, hypocapnic alkalosis 
stimulates neutrophil oxidant generation [20]. Inhibition 
of the intracellular pH changes with acetazolamide 
attenuated these eﬀ   ects. More recently, hypercapnic 
acidosis has been demonstrated to reduce oxidative 
reactions in the endotoxin injured lung by a mechanism 
involving inhibition of myeloperoxidase-dependent 
oxida  tion [26]. Th   e potential for hypercapnic acidosis to 
reduce free radical formation, while beneﬁ  cial where host 
oxidative injury is a major component of the injury 
process, may be disadvantageous in sepsis, where free 
radicals are necessary to cause bacterial injury and death.
Neutrophil apoptosis following phagocytic activity 
generally occurs within 48 hours of release into the 
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causes release of intracellular contents, including harmful 
enzymes, which can cause tissue destruction. Neutrophils 
appear to have an increased probability of dying by 
necrosis following intracellular acidiﬁ  cation  during 
phagocytosis [27]. Hypercapnic acidosis may, therefore, 
increase the probability of neutrophil cell death occurring 
via necrosis rather than apoptosis.
Hypercapnia and the adaptive immune response
Th  e adaptive immune system is activated by the innate 
response following activation of pattern recognition 
receptors that detect molecular signatures from micro-
bial pathogens. Speciﬁ  c major histocompatibility complex 
molecules on T and B lymphocytes also bind microbial 
components. Th   ese activation events lead to the genera-
tion of T and B lymphocyte-mediated immune responses 
over a period of several days.
Much of the focus to date regarding the eﬀ  ects  of 
hypercapnic acidosis on immune response to injury and/
or infection has been on the innate immune response. 
Less is known about the eﬀ  ects of hypercapnic acidosis 
on adaptive or acquired immunity. However, important 
clues as to the potential for hypercapnic acidosis to 
modulate the adaptive response come from the cancer 
literature. Th   e tumor microenvironment is characterized 
by poor vascularization, resulting in tissue hypoxia and 
acidosis. In a situation analogous to sepsis, acidosis in 
this setting may hamper the host immune response to 
tumor cells, potentially leading to increased tumor 
growth and spread. Th  e cytotoxic activity of human 
lympho  kine activated killer cells and natural killer cells is 
diminished at acidic pH [28]. Metabolic acidosis reduces 
lysis of various tumor cell lines by cytotoxic T-lympho-
cytes [29]. In contrast, the motility of IL-2-stimulated 
lymphocytes appears to be stimulated in the presence of 
an acidiﬁ  ed extracellular matrix and severe extracellular 
acidosis (pH 6.5) also appears to enhance the antigen 
presenting capacity of dendritic cells [30]. Th   e net eﬀ  ect 
of these contrasting actions of metabolic acidosis on the 
adaptive immune response is unclear. However, the 
demonstration that hypercapnic acidosis enhanced 
systemic tumor spread in a murine model [31] raises 
clear concerns regarding the potential for hypercapnic 
acidosis to suppress cell-mediated immunity.
Hypercapnia and acidosis modulate bacterial 
proliferation
Carbon dioxide has broadly similar eﬀ   ects within the 
various families of microorganisms, but the sensitivity to 
CO2 varies across the families, e.g., yeasts are quite 
resistant to the inhibitory eﬀ  ects of CO2, Gram-positive 
organisms are somewhat less resistant, and Gram-
negative organisms are the most vulnerable [32]. Optimal 
anaerobic E. coli growth occurs at a CO2 tension (PCO2) 
of 0.05 atmospheres, which is similar to the PCO2 in the 
gut. Th   e aerobic growth rate of E. coli was not inhibited 
by a PCO2 of 0.2 atmospheres but was inhibited at partial 
pressures above 0.6 atmospheres [33]. It is important to 
remember that these levels are extremely high in the 
context of human physiology.
Of concern, however, is the demonstration by Pugin et 
al. that more clinically relevant degrees of metabolic 
acidosis can directly enhance bacterial proliferation in 
vitro [34]. Cultured lung epithelial cells exposed to cyclic 
stretch similar to that seen with mechanical ventilation 
produced a lactic acidosis that markedly enhanced the 
growth of E. coli [34]. Th   is was a direct eﬀ  ect of hydrogen 
ions, as direct acidiﬁ  cation of the culture medium to a 
pH of 7.2 with hydrochloric acid enhanced E. coli growth. 
In contrast, alkalinizing the pH of conditioned media 
from stretched lung cells abolished the enhancement of 
E. coli growth. A range of Gram-positive and Gram-
negative bacteria (including E. coli, Proteus mirabilis, 
Serratia rubidaea, Klebsiella pneumoniae, Enterococcus 
faecalis, and Pseudomonas aeruginosa) isolated from 
patients with ventilator-associated pneumonia (VAP), 
grew better in acidiﬁ  ed media (Fig. 1). Interestingly, this 
eﬀ  ect was not seen with a methicillin resistant Staphylo-
coccus aureus (MRSA) strain, which appeared to grow 
best at an alkaline pH [34].
Th  e  eﬀ   ects of hypercapnic acidosis on bacterial 
proliferation at levels encountered in the context of 
permissive hypercapnia are unclear. Th  e net eﬀ  ect  is 
likely to be a combination of the eﬀ  ects of the acidosis 
and of the hypercapnia. Nevertheless, the demonstration 
that clinically relevant levels of metabolic acidosis 
enhance bacterial growth is of concern.
Implications for hypercapnia in sepsis
Immunocompetence is essential to an eﬀ  ective  host 
response to microbial infection. Hypercapnia and/or 
acidosis may modulate the interaction between host and 
bacterial pathogen via several mechanisms, resulting in a 
broad based suppression of the inﬂ  ammatory response.
Hypercapnia, acidosis and the host response
Th   e initial host response to invading pathogens is domi-
nated by neutrophil activation, migration to the infective 
site, and phagocytosis and killing of bacteria. Compart-
mentalized release of neutrophil proteolytic enzymes and 
myeloperoxidase-dependent oxygen radicals results in 
eﬀ   ective pathogen destruction. However, excessive 
release of these potent mediators into the extracellular 
space results in damage to host tissue and worsening ALI. 
Consistent with this is the ﬁ   nding that recovery of 
neutrophil count in neutropenic patients worsens the 
severity of ALI [35]. Hypercapnic acidosis may reduce 
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response to infection, by reducing lung neutrophil 
recruit  ment [10], adherence [16], intracellular pH 
regulation [12], oxidant generation [8], and phagocytosis 
[23]. Th   ese mechanisms are considered to underlie some 
of the protective eﬀ  ects of hypercapnic acidosis in non-
sepsis induced ALI [7]. However, these eﬀ  ects of hyper-
capnic acidosis may be detrimental in sepsis, given the 
central role of neutrophil mediated phagocytosis of 
microbial pathogens and activation of the cytokine 
cascade to the host response to infection. In this context, 
defects in neutrophil function are associated with 
increased sepsis severity and worse outcome [36].
Early versus late bacterial infection
Th  e  eﬀ  ects of this hypercapnic acidosis-induced immune 
modulation may vary depending upon the stage of the 
infective process. Th  e anti-inﬂ   ammatory properties of 
hypercapnic acidosis may reduce the intensity of the 
initial host response to infection, thus attenuating tissue 
damage (Fig. 2). However, the mechanisms whereby bac-
teria mediate tissue injury are complex and not limited to 
the contribution from an excessive host response. In late 
or prolonged pneumonia, in which tissue injury from 
direct bacterial spread and invasion makes a signiﬁ  cant 
contribution, hypercapnic acidosis might impair 
bactericidal host responses. In the absence of eﬀ  ective 
antibiotic therapy, this may lead to enhanced bacterial 
spread and replication leading to more severe tissue 
destruction and lung and systemic organ injury (Fig. 2).
Impact on repair following injury
Hypercapnic acidosis has been demonstrated to retard 
the repair process following lung cell and tissue injury. 
Hypercapnia slowed resealing of stretch-induced cell 
membrane injuries [37] and inhibited the repair of 
pulmo  nary epithelial wounds [18] by a mechanism 
involv  ing inhibition of the NF-κB pathway. Th  ese  ﬁ  ndings 
raise the potential that hypercapnic acidosis could lead to 
increased bacterial translocation through defects in the 
pulmonary epithelium, while also delaying the recovery 
process following a septic insult.
Recent studies in relevant preclinical models have 
signiﬁ  cantly advanced our understanding of the eﬀ  ects of 
hypercapnic acidosis in both pulmonary and systemic 
sepsis-induced ALI/ARDS. Th  ese studies reveal the 
importance of severity, site, and stage of the infective 
process, the need for antibiotic therapy, and the utility of 
buﬀ  ering the hypercapnic acidosis in this setting.
Hypercapnia in pulmonary sepsis
Early lung infection
Th  e  eﬀ  ect of hypercapnic acidosis on pneumonia-induced 
ALI appears to depend on the stage and severity of the 
infection. In an acute severe bacterial pneumonia-
induced lung injury, hypercapnic acidosis improved 
physio  logical indices of injury [38]. Intriguingly, these 
protective eﬀ  ects were mediated by a mechanism inde-
pen  dent of neutrophil function. In contrast, hypercapnic 
acidosis did not alter the magnitude of lung injury in a 
less severe acute bacterial pneumonia [39]. Importantly 
these in vivo studies showed no increase in bacterial 
count in animals exposed to hypercapnic acidosis, a 
reassuring ﬁ  nding given concerns regarding retardation 
of the host bactericidal response and potential bacterial 
proliferation.
In the clinical setting, many critically ill patients will 
have established infection at the time of presentation. 
Figure 1. Bacterial pathogens proliferate more rapidly in the 
setting of metabolic acidosis. All bacterial strains tested, except for 
a methicillin-resistant S. aureus, had a marked growth advantage at 
moderately acidic pH levels (7.2–7.6) relevant to the clinical setting. 
Gram-negative bacteria are represented by dark blue bars while 
Gram-positive bacteria are represented by light blue bars. From [34] 
with permission.
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in which hypercapnic acidosis was introduced several 
hours following induction of infection with E. coli, more 
closely resemble the clinical setting. In an established 
pneumonia model, hypercapnic acidosis induced after 
the development of a signiﬁ  cant  pneumonia-induced 
lung injury reduced physiological indices of lung injury 
[40]. Of importance, these protective eﬀ  ects of hyper  cap-
nic acidosis were enhanced in the presence of appropriate 
antibiotic therapy [40]. Again, reassuringly, lung bacterial 
loads were similar in the hypercapnic acidosis and 
normo  capnia groups [40].
Prolonged lung infection
In an animal model of prolonged untreated pneumonia, 
sustained hypercapnic acidosis worsened histological and 
physiological indices of lung injury, including compliance, 
arterial oxygenation, alveolar wall swelling and neutrophil 
inﬁ   ltration [23]. Of particular concern to the clinical 
setting, hypercapnic acidosis was associated with a higher 
lung bacterial count. Th   e mechanism underlying this eﬀ  ect 
appeared to be inhibition of neutrophil function, as 
evidenced by impaired phagocytotic ability in neutrophils 
isolated from hypercapnic rats [23]. Of importance to the 
clinical context, the use of appropriate antibiotic therapy 
abolished these deleterious eﬀ   ects of hypercapnia, 
reducing lung damage and lung bacterial load to levels 
comparable to those seen with normocapnia.
Th  ese ﬁ  ndings have been conﬁ  rmed and considerably 
expanded in a recent study of hypercapnia in the fruit ﬂ  y 
[41]. Helenius et al., in a series of elegant in vivo studies, 
found that prolonged hypercapnia decreased expression 
of speciﬁ   c anti-microbial peptides in Drosophilia 
melano gaster [41]. Hypercapnia decreased bacterial 
resis  tance in adult ﬂ   ies exposed to pathogens as 
evidenced by increased bacterial loads and increased 
mortality in ﬂ  ies inoculated with E. faecalis, A. tume-
faciens, or S. aureus [41]. Th  e previously demon  strated 
suppressive eﬀ  ects of hypercapnic acidosis on the NF-κB 
pathway appeared to underlie the decreased resistance to 
infection [41]. Th  ese ﬁ  ndings raise signiﬁ  cant concerns 
regarding the safety of hypercapnia in the setting of 
prolonged pneumonia, particularly in the absence of 
eﬀ  ective antibiotic therapy.
Figure 2. Potential mechanisms underlying the eff  ects of hypercapnic acidosis in sepsis. Panel A represents early sepsis, in which 
hypercapnic acidosis may reduce the host infl  ammatory response and decrease the contribution of bacterial toxin mediated injury to tissue injury 
and damage. This might result in an overall decrease in lung injury. Panel B represents late or prolonged bacterial sepsis, where a hypercapnic 
acidosis-mediated decrease in the host response to bacterial infection might result in unopposed bacterial proliferation, thereby increasing direct 
bacterial tissue invasion and injury, and worsening lung injury. ALI: acute lung injury; HCA: hypercapnic acidosis.
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A growing body of evidence attests to a beneﬁ  cial role of 
hypercapnia in the setting of systemic sepsis. Improve-
ments in hemodynamic parameters and lung injury have 
been demonstrated in evolving, established, and pro-
longed systemic sepsis in animal models. Th  is is in 
contrast to the detrimental eﬀ   ects of hypercapnic 
acidosis seen in prolonged pulmonary sepsis, suggesting 
that the eﬀ  ects of hypercapnic acidosis depend not only 
on the stage of the infective process, but also on the site 
of the primary infection.
Early systemic sepsis
Hypercapnic acidosis reduces the severity of early septic 
shock and lung injury induced by systemic sepsis. In a 
rodent model of peritoneal sepsis induced by cecal 
ligation and puncture, hypercapnic acidosis slowed the 
development of hypotension, preserved central venous 
oxygen saturation, and attenuated the rise in serum 
lactate compared to control conditions, in the ﬁ  rst 
3 hours post injury [42]. Th   e severity of early lung injury 
was reduced as evidenced by a decrease in the alveolar-
arterial oxygen gradient, and reduced lung permeability, 
compared to normocapnia. Alveolar neutrophil concen-
tration was reduced by hypercapnic acidosis but IL-6 and 
TNF-α were unchanged [42]. Of importance, there were 
no diﬀ  erences in bacterial loads in the lung, blood, or 
peritoneum in the hypercapnia group.
Prolonged systemic sepsis
Using an ovine model of fecal peritonitis, Wang et al 
compared the eﬀ  ects of hypercapnic acidosis with those 
of dobutamine [43]. Over an 18-hour study period, 
hyper  capnic acidosis resulted in improved hemo-
dynamics of a magnitude comparable to that of dobu-
tamine. Compared with normocapnia, both hypercapnic 
acidosis and dobutamine raised cardiac index and 
systemic oxygen delivery and reduced lactate levels. In 
addition, hyper  capnic acidosis attenuated indices of lung 
injury, including lung edema, alveolar-arterial oxygen 
partial pressure diﬀ   erence and shunt fraction. Hyper-
capnic acidosis did not decrease survival time compared 
to normo  capnia in this setting [43]. In a more prolonged 
systemic sepsis model, Costello et al. demonstrated that 
sustained hypercapnic acidosis reduced histological 
indices of lung injury compared with normocapnia in 
rodents following cecal ligation and puncture [42]. 
Reassuringly there was no evidence of an increased 
bacterial load in the lung, blood, or peritoneum of 
animals exposed to hypercapnia.
Intraperitoneal hypercapnia
Direct intra-abdominal administration of CO2 – by 
means of a pneumoperitoneum – reduces the severity of 
abdominal sepsis-induced lung and systemic organ 
injury. Insuﬄ   ation of CO2 into the peritoneal cavity prior 
to laparotomy for endotoxin contamination increased 
animal survival [44]. Most recently, CO2 pneumo  peri-
toneum has been demonstrated to increase survival in 
mice with polymicrobial peritonitis induced by cecal 
ligation and puncture  (Fig.  3)  [31]. Th  ese protective 
eﬀ   ects of intraperitoneal carbon dioxide insuﬄ   ation 
appear be due to the immunomodulatory eﬀ  ects  of 
hyper  capnic acidosis, which include an IL-10 mediated 
downregulation of TNF-α [44]. Importantly, these eﬀ  ects 
appear to be mediated by the localized peritoneal 
acidosis, rather than by any systemic eﬀ  ect.
Buff  ering hypercapnic acidosis in sepsis
Th  e immunomodulatory eﬀ  ects of hypercapnic acidosis 
in sepsis may occur as a function of either hypercapnia or 
acidosis. As discussed, evidence suggests that hyper-
capnic acidosis exerts certain eﬀ  ects via its associated 
acidosis [24], while other eﬀ  ects appear be a function of 
the hypercapnia per se [17]. Buﬀ  ered hypercapnia, i.e., 
hypercapnia in the presence of normal pH, may be seen 
in ALI/ARDS patients as a renal compensatory measure, 
or as a result of the administration of bicarbonate, a 
common clinical practice in the ICU, and one that was 
Figure 3. Insuffl   ation of CO2 into the peritoneal cavity improves 
survival following cecal ligation and puncture-induced systemic 
sepsis. Animals were fi  rst subjected to cecal ligation and puncture. 
Four hours later, animals underwent a laparotomy and induction of 
a CO2 pneumoperitoneum (laparotomy + CO2), laparotomy alone, or 
no laparotomy; survival was determined over the following 8 days. 
Modifi  ed from [31] with permission.
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from well established concerns regarding the use of 
sodium bicarbonate, there is evidence from animal models 
of lung and systemic sepsis that the anti-inﬂ  am  matory and 
protective eﬀ   ects of hypercapnic acidosis are lost with 
buﬀ  ering.  Th  is has signiﬁ   cant implications in clinical 
scenarios where the buﬀ   ering of hypercapnia resulting 
from protective ventilator strategies is considered.
Pulmonary sepsis
In rodent models of acute pneumonia induced by intra-
tracheal  E. coli and by endotoxin, buﬀ  ered hypercapnia 
worsened lung injury [24]. Compared with normocapnic 
controls, buﬀ  ered hypercapnia increased multiple indices 
of lung injury including arterial oxygenation, lung compli-
ance, pro-inﬂ   ammatory pulmonary cytokine concen-
trations, and measurements of structural lung damage. In 
these experiments, buﬀ  ered hypercapnia was established 
in the animals by exposure to hypercapnic conditions until 
renal buﬀ  ering to normal pH had occurred, thus avoiding 
the confounding eﬀ   ects of exogenous acid or alkali 
administration. Th  is contrasts with the protective eﬀ  ects 
of hypercapnic acidosis in similar models [11,38]. Of note, 
buﬀ   ered hypercapnia did not reduce the phagocytic 
capacity of neutrophils, and did not increase lung bacterial 
load in these studies [24].
Systemic sepsis
In a study designed to assess the contribution of acidosis 
versus hypercapnia to the eﬀ  ects of hypercapnic acidosis 
on the lung and hemodynamic proﬁ  le in systemic sepsis, 
Higgins et al. exposed rats to environmental hypercapnia 
until renal buﬀ  ering had restored pH to the normal range 
[45]. Both buﬀ  ered hypercapnia and hypercapnic acidosis 
reduced the severity of early shock and attenuated the 
increase in serum lactate compared with normocapnia. 
In contrast, buﬀ   ered hypercapnia did not attenuate 
physiologic or histologic indices of lung injury in these 
studies [45]. Reassuringly, there was no evidence to 
suggest that buﬀ  ered hypercapnia worsened the degree 
of lung injury compared to normocapnia, and buﬀ  ered 
hypercapnia did not increase the bacterial load in the 
lungs or the bloodstream [45].
Hypercapnia and sepsis: where are we now?
Th   e generally beneﬁ  cial eﬀ  ects of hypercapnic acidosis in 
the setting of experimental non-septic inﬂ  ammatory 
injury contrast with a more complex spectrum of eﬀ  ects 
in the setting of live bacterial infection. Hypercapnia and/
or acidosis exert diverse – and potentially conﬂ  icting – 
eﬀ  ects on the innate and adaptive immune responses. 
Overall, hypercapnic acidosis appears to suppress the 
immune response, although the net eﬀ  ect of its multiple 
actions appears to vary depending on the site of infection 
and also on whether the acidosis produced by the 
hypercapnia is buﬀ   ered or not. Hypercapnic acidosis 
appears to protect the lung from injury induced by 
evolving or more established lung and systemic bacterial 
sepsis in relevant pre-clinical models. In contrast, the 
eﬀ  ects of hypercapnic acidosis in prolonged untreated 
bacterial sepsis appear to diﬀ  er depending on the source 
of the infection, with the immunosuppressive eﬀ  ects of 
hypercapnic acidosis worsening lung injury in the setting 
of prolonged pneumonia. Th  is deleterious eﬀ  ect  is 
abrogated by eﬀ   ective antibiotic therapy. In contrast, 
hyper  capnic acidosis reduced lung damage caused by 
pro  longed systemic sepsis, again highlighting the poten-
tial importance of the source of infection. Finally, buﬀ  er-
ing of the acidosis induced by hypercapnia does not 
confer signiﬁ  cant  beneﬁ   t in the setting of lung or 
systemic sepsis, and may actually worsen lung injury in 
the setting of pneumonia.
Taken together, recent experimental ﬁ  ndings  in 
relevant pre-clinical models provide some reassurance 
regarding the safety of hypercapnia in sepsis, particularly 
in early pneumonia, and in the setting of abdominal 
sepsis. However, in the setting of prolonged pneumonia, 
the immunosuppressive eﬀ  ects of hypercapnia remain a 
concern. While the use of ventilation strategies resulting 
in hypercapnia is clearly justiﬁ  ed in patient with ALI/
ARDS, care is warranted in the setting of sepsis. Th  e 
ﬁ   nding that deleterious eﬀ   ects of hypercapnia in the 
setting of prolonged pneumonia are abrogated by appro-
priate antibiotic therapy is of importance.
Clinicians should carefully consider the use of early 
empiric antibiotic therapy in hypercapnic ALI/ARDS 
patients in whom sepsis is suspected or conﬁ  rmed. 
However, concerns persist, particularly where antibiotic 
cover may be suboptimal, or the bacteria are more 
resistant to antibiotic therapy. Th  e ﬁ  ndings that hyper-
capnia may increase septic lung injury in the setting of 
prolonged pneumonia is also of relevance to other patient 
groups, such as patients with infective exacerbations of 
chronic obstructive airways disease.
Conclusion
Hypercapnia is an integral component of protective lung 
ventilatory strategies in patients with severe respiratory 
failure. Th  e potential for hypercapnia to modulate the 
immune response, and the mechanisms underlying these 
eﬀ  ects are increasingly well understood. Th  e  ﬁ  ndings that 
hypercapnic acidosis is protective in systemic sepsis, and 
in the earlier phases of pneumonia-induced sepsis, 
provide reassurance regarding the safety of hypercapnia 
in the clinical setting. However, the potential for hyper-
capnic acidosis to worsen injury in the setting of pro-
longed lung sepsis must be recognized. Additional 
studies are needed to further elucidate the mechanisms 
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Page 7 of 9underlying the eﬀ  ects of hypercapnia and acidosis in the 
setting of sepsis-induced lung injury.
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